1. Home
  2. OSBC vs VIR Comparison

OSBC vs VIR Comparison

Compare OSBC & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSBC
  • VIR
  • Stock Information
  • Founded
  • OSBC 1981
  • VIR 2016
  • Country
  • OSBC United States
  • VIR United States
  • Employees
  • OSBC N/A
  • VIR N/A
  • Industry
  • OSBC Major Banks
  • VIR Biotechnology: Pharmaceutical Preparations
  • Sector
  • OSBC Finance
  • VIR Health Care
  • Exchange
  • OSBC Nasdaq
  • VIR Nasdaq
  • Market Cap
  • OSBC 708.1M
  • VIR 844.9M
  • IPO Year
  • OSBC N/A
  • VIR 2019
  • Fundamental
  • Price
  • OSBC $16.59
  • VIR $5.09
  • Analyst Decision
  • OSBC Buy
  • VIR Strong Buy
  • Analyst Count
  • OSBC 5
  • VIR 7
  • Target Price
  • OSBC $20.00
  • VIR $33.57
  • AVG Volume (30 Days)
  • OSBC 228.8K
  • VIR 1.0M
  • Earning Date
  • OSBC 04-23-2025
  • VIR 05-07-2025
  • Dividend Yield
  • OSBC 1.43%
  • VIR N/A
  • EPS Growth
  • OSBC N/A
  • VIR N/A
  • EPS
  • OSBC 1.83
  • VIR N/A
  • Revenue
  • OSBC $275,720,000.00
  • VIR $20,861,000.00
  • Revenue This Year
  • OSBC $17.44
  • VIR N/A
  • Revenue Next Year
  • OSBC $14.38
  • VIR $10.65
  • P/E Ratio
  • OSBC $9.16
  • VIR N/A
  • Revenue Growth
  • OSBC 2.88
  • VIR N/A
  • 52 Week Low
  • OSBC $13.27
  • VIR $4.95
  • 52 Week High
  • OSBC $19.46
  • VIR $14.45
  • Technical
  • Relative Strength Index (RSI)
  • OSBC 60.17
  • VIR 31.53
  • Support Level
  • OSBC $15.53
  • VIR $5.04
  • Resistance Level
  • OSBC $16.95
  • VIR $6.29
  • Average True Range (ATR)
  • OSBC 0.59
  • VIR 0.30
  • MACD
  • OSBC 0.19
  • VIR -0.02
  • Stochastic Oscillator
  • OSBC 82.53
  • VIR 3.57

About OSBC Old Second Bancorp Inc.

Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The Company has one operating segment, which is community banking. The company's revenue consists of interest, commission, payments, and other income.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: